Intercept Pharmaceuticals Inc (ICPT)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: ICPT Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-03-12 2021-03-12 B Purchase

AKKARAJU SRINIVAS

Non-Executive Director
147,000 +29.8%
21.29
3,129,630 USD 		147,000 +29.8% 21.29 3,129,630 USD
2021-03-12 2021-03-10 B Purchase

AKKARAJU SRINIVAS

Non-Executive Director
16,559 +3.5%
21.55
356,846 USD 		16,559 +3.5% 21.55 356,846 USD
2021-03-12 2021-03-10 B Purchase

AKKARAJU SRINIVAS

Non-Executive Director
73,441 +18.2%
20.83
1,529,776 USD 		73,441 +18.2% 20.83 1,529,776 USD
2021-01-05 2021-01-05 PS Planned sale

Kapadia Sandip

CFO and Treasurer

Officer
2,193 -8.4%
24.47
53,663 USD 		2,193 -8.4% 24.47 53,663 USD
2020-12-16 2020-12-15 PS Planned sale

Kapadia Sandip

CFO and Treasurer

Officer
1,763 -6.1%
32.78
57,791 USD 		1,763 -6.1% 32.78 57,791 USD
2020-08-20 2020-08-18 S Sale

Campagna Jason

Chief Medical Officer

Officer
1,192 -12.0%
47.44
56,543 USD 		1,192 -12.0% 47.44 56,543 USD
2020-08-17 2020-08-17 S Sale

Genextra S.p.A.

Large shareholder
1,235,512 -23.6%
46.75
57,760,186 USD 		1,235,512 -23.6% 46.75 57,760,186 USD
2020-08-17 2020-08-17 S Sale

Genextra S.p.A.

Large shareholder
126,888 -2.4%
50.15
6,362,913 USD 		126,888 -2.4% 50.15 6,362,913 USD
2020-08-17 2020-08-17 S Sale

Fundaro Paolo

Non-Executive Director Large shareholder
1,235,512 -23.6%
46.75
57,760,186 USD 		1,235,512 -23.6% 46.75 57,760,186 USD
2020-08-17 2020-08-17 S Sale

Fundaro Paolo

Non-Executive Director Large shareholder
126,888 -2.4%
50.15
6,362,913 USD 		126,888 -2.4% 50.15 6,362,913 USD
2020-08-17 2020-08-17 S Sale

Micheli Francesco

Large shareholder
1,235,512 -23.6%
46.75
57,760,186 USD 		1,235,512 -23.6% 46.75 57,760,186 USD
2020-08-17 2020-08-17 S Sale

Micheli Francesco

Large shareholder
126,888 -2.4%
50.15
6,362,913 USD 		126,888 -2.4% 50.15 6,362,913 USD
2020-08-17 2020-08-14 S Sale

Genextra S.p.A.

Large shareholder
54,600 -1.0%
50.55
2,760,112 USD 		54,600 -1.0% 50.55 2,760,112 USD
2020-08-17 2020-08-14 S Sale

Fundaro Paolo

Non-Executive Director Large shareholder
54,600 -1.0%
50.55
2,760,112 USD 		54,600 -1.0% 50.55 2,760,112 USD
2020-08-17 2020-08-14 S Sale

Micheli Francesco

Large shareholder
54,600 -1.0%
50.55
2,760,112 USD 		54,600 -1.0% 50.55 2,760,112 USD
2020-08-17 2020-08-13 S Sale

Fundaro Paolo

Non-Executive Director Large shareholder
83,000 -1.5%
52.60
4,365,451 USD 		83,000 -1.5% 52.60 4,365,451 USD
2020-08-17 2020-08-13 S Sale

Genextra S.p.A.

Large shareholder
83,000 -1.5%
52.60
4,365,451 USD 		83,000 -1.5% 52.60 4,365,451 USD
2020-08-17 2020-08-13 S Sale

Micheli Francesco

Large shareholder
83,000 -1.5%
52.60
4,365,451 USD 		83,000 -1.5% 52.60 4,365,451 USD
2020-05-15 2020-05-13 S Sale

Micheli Francesco

Large shareholder
595,578 -9.8%
84.60
50,385,899 USD 		595,578 -9.8% 84.60 50,385,899 USD
2020-05-15 2020-05-13 S Sale

Fundaro Paolo

Non-Executive Director Large shareholder
595,578 -9.8%
84.60
50,385,899 USD 		595,578 -9.8% 84.60 50,385,899 USD
2020-05-15 2020-05-13 S Sale

Genextra S.p.A.

Large shareholder
595,578 -9.8%
84.60
50,385,899 USD 		595,578 -9.8% 84.60 50,385,899 USD
2020-04-29 2020-04-27 PS Planned sale

Weyer Christian

EVP, Research & Development

Officer
181 -1.0%
85.95
15,557 USD 		181 -1.0% 85.95 15,557 USD
2020-04-10 2020-04-09 PS Planned sale

Ford David A

Chief Human Resources Officer

Officer
58 -0.4%
70.00
4,060 USD 		58 -0.4% 70.00 4,060 USD
2020-02-28 2020-02-27 PS Planned sale

Weyer Christian

EVP, Research & Development

Officer
113 -0.6%
87.62
9,901 USD 		113 -0.6% 87.62 9,901 USD
2020-01-27 2020-01-27 PS Planned sale

Weyer Christian

EVP, Research & Development
723 -3.9%
94.04
67,991 USD 		723 -3.9% 94.04 67,991 USD
2020-01-08 2020-01-07 PS Planned sale

Campagna Jason

Chief Medical Officer
732 -10.4%
113.02
82,731 USD 		732 -10.4% 113.02 82,731 USD
2020-01-03 2019-12-31 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
100 -0.0%
125.00
12,500 USD 		100 -0.0% 125.00 12,500 USD
2020-01-03 2019-12-31 PS Planned sale

Cawkwell Gail

SVP, Med Affairs, Safety & PV
262 -1.4%
125.00
32,750 USD 		262 -1.4% 125.00 32,750 USD
2019-12-30 2019-12-27 PS Planned sale

Weyer Christian

EVP, Research & Development

Officer
1,581 -10.0%
123.24
194,842 USD 		1,581 -10.0% 123.24 194,842 USD
2019-12-30 2019-12-26 PS Planned sale

Cawkwell Gail

SVP, Med Affairs, Safety & PV

Officer
54 -0.3%
125.00
6,750 USD 		54 -0.3% 125.00 6,750 USD
2019-12-30 2019-12-26 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
417 -0.1%
125.00
52,125 USD 		417 -0.1% 125.00 52,125 USD
2019-12-20 2019-12-19 PS Planned sale

Campagna Jason

Chief Medical Officer

Officer
154 -2.0%
119.45
18,395 USD 		154 -2.0% 119.45 18,395 USD
2019-12-02 2019-11-27 PS Planned sale

Weyer Christian

EVP, Research & Development

Officer
1,040 -6.2%
101.65
105,716 USD 		1,040 -6.2% 101.65 105,716 USD
2019-11-27 2019-11-26 PS Planned sale

Weyer Christian

EVP, Research & Development
4,373 -21.7%
100.00
437,300 USD 		4,373 -21.7% 100.00 437,300 USD
2019-11-27 2019-11-26 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
35,437 -7.0%
100.00
3,543,700 USD 		35,437 -7.0% 100.00 3,543,700 USD
2019-11-27 2019-11-25 PS Planned sale

Weyer Christian

EVP, Research & Development
1,855 -10.5%
100.00
185,500 USD 		1,855 -10.5% 100.00 185,500 USD
2019-11-27 2019-11-25 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
14,563 -3.0%
100.00
1,456,300 USD 		14,563 -3.0% 100.00 1,456,300 USD
2019-11-19 2019-11-19 PS Planned sale

Weyer Christian

EVP, Research & Development

Officer
1,550 -9.0%
85.00
131,750 USD 		1,550 -9.0% 85.00 131,750 USD
2019-11-19 2019-11-19 PS Planned sale

Sullivan Ryan T

General Counsel and Secretary

Officer
3,829 -14.9%
85.00
325,465 USD 		3,829 -14.9% 85.00 325,465 USD
2019-11-19 2019-11-19 PS Planned sale

Sullivan Ryan T

General Counsel and Secretary

Officer
8,325 -24.5%
85.00
707,625 USD 		8,325 -24.5% 85.00 707,625 USD
2019-11-15 2019-11-13 PS Planned sale

Weyer Christian

EVP, Research & Development
946 -5.2%
85.00
80,410 USD 		946 -5.2% 85.00 80,410 USD
2019-11-15 2019-11-13 PS Planned sale

Sullivan Ryan T

General Counsel and Secretary
500 -1.9%
85.00
42,500 USD 		500 -1.9% 85.00 42,500 USD
2019-10-31 2019-10-29 PS Planned sale

Bright Lisa

President, International
595 -3.1%
75.00
44,625 USD 		595 -3.1% 75.00 44,625 USD
2019-10-25 2019-10-23 PS Planned sale

Ford David A

Chief Human Resources Officer
58 -0.5%
70.00
4,060 USD 		58 -0.5% 70.00 4,060 USD
2019-09-18 2019-09-16 PS Planned sale

Ford David A

Chief Human Resources Officer
800 -6.5%
70.00
56,000 USD 		800 -6.5% 70.00 56,000 USD
2019-08-30 2019-08-28 B Purchase

AKKARAJU SRINIVAS

Non-Executive Director
5,207 +1.3%
60.32
314,086 USD 		5,207 +1.3% 60.32 314,086 USD
2019-07-03 2019-07-03 PS Planned sale

Bright Lisa

President, International
595 -2.9%
78.66
46,803 USD 		595 -2.9% 78.66 46,803 USD
2019-05-14 2019-05-14 B Purchase

Benatti Luca

Non-Executive Director
1,200 +18.9%
83.50
100,200 USD 		1,200 +18.9% 83.50 100,200 USD
2019-05-03 2019-05-01 PS Planned sale

Shapiro David

Chief Medical Officer

Officer
2,000 -4.8%
86.28
172,560 USD 		2,000 -4.8% 86.28 172,560 USD
2019-04-16 2019-04-15 PS Planned sale

Shapiro David

Chief Medical Officer
2,000 -4.8%
95.00
190,000 USD 		2,000 -4.8% 95.00 190,000 USD
2019-04-03 2019-04-03 PS Planned sale

Shapiro David

Chief Medical Officer
562 -1.4%
115.01
64,636 USD 		562 -1.4% 115.01 64,636 USD
2019-04-03 2019-04-03 PS Planned sale

Bright Lisa

President, International
594 -2.8%
115.01
68,316 USD 		594 -2.8% 115.01 68,316 USD
2019-03-29 2019-03-29 PS Planned sale

Fundaro Paolo

2,171 -16.3%
107.45
233,272 USD 		2,171 -16.3% 107.45 233,272 USD
2019-03-01 2019-03-01 PS Planned sale

Weyer Christian

EVP, Research & Development

Officer
333 -1.7%
103.16
34,352 USD 		333 -1.7% 103.16 34,352 USD
2019-03-01 2019-03-01 PS Planned sale

Shapiro David

Chief Medical Officer

Officer
2,000 -4.7%
103.16
206,320 USD 		2,000 -4.7% 103.16 206,320 USD
2019-02-21 2019-02-19 PS Planned sale

AKKARAJU SRINIVAS

Non-Executive Director
23,438 -10.0%
128.78
3,018,346 USD 		23,438 -10.0% 128.78 3,018,346 USD
2019-02-20 2019-02-15 PS Planned sale

Shapiro David

Chief Medical Officer

Officer
2,000 -4.7%
111.51
223,020 USD 		2,000 -4.7% 111.51 223,020 USD
2019-01-09 2019-01-07 PS Planned sale

Bright Lisa

President, International

Officer
1,313 -6.5%
104.93
137,773 USD 		1,313 -6.5% 104.93 137,773 USD
2019-01-04 2019-01-04 PS Planned sale

Shapiro David

Chief Medical Officer

Officer
474 -1.3%
97.48
46,206 USD 		474 -1.3% 97.48 46,206 USD
2020-01-03 2019-01-03 PS Planned sale

Ford David A

Chief Human Resources Officer
259 -2.4%
117.16
30,344 USD 		259 -2.4% 117.16 30,344 USD
2019-01-03 2019-01-03 PS Planned sale

Shapiro David

Chief Medical Officer

Officer
699 -1.8%
97.45
68,118 USD 		699 -1.8% 97.45 68,118 USD
2019-01-03 2019-01-02 PS Planned sale

Shapiro David

Chief Medical Officer

Officer
2,000 -4.9%
98.28
196,560 USD 		2,000 -4.9% 98.28 196,560 USD
2018-12-19 2018-12-17 PS Planned sale

Shapiro David

Chief Medical Officer

Officer
2,000 -4.9%
106.62
213,240 USD 		2,000 -4.9% 106.62 213,240 USD
2018-12-06 2018-12-04 S Sale

Bright Lisa

President, International

Officer
300 -1.4%
111.00
33,300 USD 		300 -1.4% 111.00 33,300 USD
2018-12-06 2018-12-03 S Sale

Bright Lisa

President, International

Officer
200 -0.9%
113.22
22,645 USD 		200 -0.9% 113.22 22,645 USD
2018-12-06 2018-12-03 S Sale

Bright Lisa

President, International

Officer
700 -3.1%
112.12
78,486 USD 		700 -3.1% 112.12 78,486 USD
2018-12-06 2018-12-03 S Sale

Bright Lisa

President, International

Officer
3,800 -14.5%
111.23
422,691 USD 		3,800 -14.5% 111.23 422,691 USD
2018-12-03 2018-11-29 S Sale

Genextra S.p.A.

750,000 -11.0%
105.07
78,802,500 USD 		750,000 -11.0% 105.07 78,802,500 USD
2018-12-03 2018-11-29 S Sale

Micheli Francesco

750,000 -11.0%
105.07
78,802,500 USD 		750,000 -11.0% 105.07 78,802,500 USD
2018-11-29 2018-11-29 PS Planned sale

Weyer Christian

EVP, Research & Development

Officer
1,343 -7.8%
113.78
152,807 USD 		1,343 -7.8% 113.78 152,807 USD
2018-11-16 2018-11-16 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
1,988 -0.3%
103.29
205,333 USD 		1,988 -0.3% 103.29 205,333 USD
2018-11-16 2018-11-16 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
7,839 -1.4%
102.61
804,374 USD 		7,839 -1.4% 102.61 804,374 USD
2018-11-16 2018-11-16 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
7,949 -1.4%
101.48
806,687 USD 		7,949 -1.4% 101.48 806,687 USD
2018-11-16 2018-11-16 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
9,830 -1.7%
100.38
986,735 USD 		9,830 -1.7% 100.38 986,735 USD
2018-11-16 2018-11-15 PS Planned sale

Pruzanski Mark

President & CEO

Executive Director
3,521 -0.6%
101.13
356,088 USD 		3,521 -0.6% 101.13 356,088 USD